Isolation of 4/91 Type of Infectious Bronchitis Virus as a New Variant in Japan and Efficacy of Vaccination Against 4/91 Type Field Isolate
Among field isolates of infectious bronchitis virus (IBV) from recent outbreaks, some isolates that were classified into the 4/91 genotype, by analysis of the S1 gene, have been confirmed to be a new variant in Japan. To elucidate the characteristics of these isolates, pathogenicity in chicks and th...
Saved in:
Published in: | Avian diseases Vol. 52; no. 4; pp. 618 - 622 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
American Association of Avian Pathologists
01-12-2008
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Among field isolates of infectious bronchitis virus (IBV) from recent outbreaks, some isolates that were classified into the 4/91 genotype, by analysis of the S1 gene, have been confirmed to be a new variant in Japan. To elucidate the characteristics of these isolates, pathogenicity in chicks and the efficacy of vaccines against this new variant were examined. Severe respiratory symptoms were observed in 4-day-old specific pathogen free chicks inoculated with a 4/91 genotype isolate, either JP/Wakayama/2003 or JP/Iwate/2005; body weights 3 wk after inoculation were significantly lower than those of chicks inoculated with a 4/91 vaccine strain. These 4/91 isolates were neutralized with serum from birds immunized with 4/91 vaccine. In a challenge–protection test, five groups of chicks were immunized with C78, TM-86w, H120, Kita-1, or 4/91 vaccines and then challenged with JP/Iwate/2005 4 wk after vaccination. A protective effect in the 4/91 and TM-86w vaccine groups was indicated by evaluation of the ciliostasis score of the trachea, the respiratory symptom score, and virus isolation from trachea swab samples after challenge. The results of this study suggested that the 4/91 type of IBV, which is virulent to chicks when compared to vaccine strains, has emerged as a new variant in Japan, and vaccines containing the 4/91 strain or the TM-86w strain could be effective for this variant. Abbreviations: DPC = days postchallenge; DPI = days postinfection; EID50 = 50% embryo infectious dose; HVR = hypervariable region; IB = infectious bronchitis; IBV = infectious bronchitis virus; PBS = phosphate buffered saline; RT-PCR = reverse transcriptase–polymerase chain reaction; SPF = specific pathogen-free; VN = virus-neutralizing Aislamiento de un virus del tipo 4/91 como una nueva variante del virus de bronquitis infecciosa en Japón y eficacia de la vacunación contra una cepa de campo. Entre los aislados de campo de virus de bronquitis infecciosa ocurridos recientemente, algunos aislados fueron clasificados como del genotipo 4/91, mediante el análisis del gen S1. Este tipo ha sido confirmado como una nueva variante en Japón. Para conocer las características de estas cepas, se evaluó la patogenicidad de las cepas en pollos y la eficacia de las vacunas. Cuando se inocularon aves libres de patógenos específicos de 4 días de edad con aislados genotipo 4/91, tanto JP/Wakayama/2003 como JP/Iwate/2005; se observaron severos síntomas respiratorios, el peso corporal 3 semanas postinoculación fue significativamente más bajo que el de aquellos pollos inoculados con una cepa vacunal 4/91. Estos aislados 4/91 fueron neutralizados con sueros provenientes de aves inmunizadas con una vacuna 4/91. En una prueba de protección al desafío, cinco grupos de pollos fueron inmunizados con vacunas C78, TM-86w, H120, Kita-1 ó 4/91 y desafiados 4 semanas después con la cepa JP/Iwate/2005. El efecto protector de las vacunas 4/91 y TM-86w fue evaluado mediante la calificación de la ciliostasis en la tráquea y los síntomas respiratorios, lo mismo que el aislamiento del virus a partir de muestras de hisopos traqueales tomadas después del desafío. Los resultados de este estudio sugieren que el virus de bronquitis infecciosa tipo 4/91, que es virulento para pollos cuando se compara con cepas vacunales, ha emergido como una nueva variante en el Japón, y las vacunas que contienen las cepas 4/91 ó la TM-86w pueden ser efectivas contra esta variante. |
---|---|
Bibliography: | http://dx.doi.org/10.1637/8359-051408-Reg.1 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0005-2086 1938-4351 |
DOI: | 10.1637/8359-051408-Reg.1 |